{
    "Trade/Device Name(s)": [
        "BD PhoenixTM Automated Microbiology System Cefoxitin 0.5-64 \u03bcg/mL EY",
        "BD PhoenixTM Automated Microbiology System for use with the antimicrobial agent Cefoxitin 0.5-64 \u00b5g/mL on Gram-negative ID/AST or AST only Phoenix panels"
    ],
    "Submitter Information": "Becton, Dickinson and Company",
    "510(k) Number": "K060257",
    "Predicate Device Reference 510(k) Number(s)": [
        "N50510",
        "K020321",
        "K032567"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LON"
    ],
    "Summary Letter Date": "January 31, 2006",
    "Summary Letter Received Date": "February 1, 2006",
    "Submission Date": "April 5, 2006",
    "Regulation Number(s)": [
        "21 CFR 866.1645"
    ],
    "Regulation Name(s)": [
        "Fully Automated Short Term Incubation Cycle Antimicrobial Susceptibility Devices"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Cefoxitin"
    ],
    "Specimen Type(s)": [
        "Pure culture isolates",
        "Gram-negative aerobic bacteria",
        "Facultative anaerobic bacteria",
        "Gram-positive bacteria"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "BD Phoenix Automated Microbiology System"
    ],
    "Method(s)/Technology(ies)": [
        "Broth microdilution",
        "Redox indicator detection",
        "Automated incubation and reading"
    ],
    "Methodologies": [
        "Antimicrobial susceptibility testing",
        "Quantitative determination of MIC"
    ],
    "Submission Type(s)": [
        "Automated system",
        "Panel",
        "Instrument",
        "Software",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for BD Phoenix Automated Microbiology System Cefoxitin panels for rapid identification and antimicrobial susceptibility testing of bacterial isolates.",
    "Indications for Use Summary": "Intended for in vitro quantitative determination of antimicrobial susceptibility by MIC of Gram-negative and Gram-positive aerobic and facultative anaerobic bacteria isolates from pure culture, including Enterobacteriaceae, Non-Enterobacteriaceae, and Staphylococcus, Enterococcus, and Streptococcus genera, using Phoenix panels containing cefoxitin 0.5-64 \u03bcg/mL.",
    "fda_folder": "Microbiology"
}